Owner Neuraxon, Inc.

Inventors Rakhit, Suman; Patman, Joanne; Annedi, Subhash C.; Renton, Paul; Maddaford, Shawn; Ramnauth, Jailall

Agent Spruson & Ferguson

Pub. Number AU-B-2006321284

PCT Pub. Number WO2007/063418

Priority 60/670,856 13.04.05 US

Filing date 13 April 2006

Wipo publication date 7 June 2007

Acceptance publication date 21 June 2012

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

A61K 31/404

A61P 25/28 Drugs for disorders of the nervous system

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 453/02 Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 471/08 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups